Kodiak Sciences Inc. (KOD) income statement
KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$97.17−0.73 (-0.75%)
Close on Nov 20, 2026Market cap $6.11BP/E –Yield –
Kodiak Sciences Inc. financial ratios
See a number that looks wrong?